Jackeline Agorreta Selected Research

Jackeline Agorreta Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 02/2006
16	Lung Neoplasms (Lung Cancer) 10/2019 - 11/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2010
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2011
7	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2010
5	Adenocarcinoma of Lung 01/2018 - 07/2012
3	Adenocarcinoma 01/2015 - 06/2011
3	Hypoxia (Hypoxemia) 01/2014 - 08/2003
2	Carcinoma (Carcinomatosis) 01/2018 - 04/2016
2	Disease Progression 01/2014 - 04/2012
2	Acute Lung Injury 03/2005 - 08/2003
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 10/2019
1	Squamous Cell Carcinoma of Head and Neck 08/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2014
1	Carcinogenesis 08/2013
1	Pneumonia (Pneumonitis) 08/2013
1	Inflammation (Inflammations) 08/2013
1	Breast Neoplasms (Breast Cancer) 12/2010
1	Ductal Carcinoma 12/2010
1	Stomach Neoplasms (Stomach Cancer) 04/2009
1	Colorectal Neoplasms (Colorectal Cancer) 04/2009
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2009

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2010
7	Biomarkers (Surrogate Marker)IBA 10/2019 - 02/2006
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
3	Dasatinib (BMS 354825)FDA Link 01/2021 - 08/2019
3	AntibodiesIBA 01/2018 - 01/2017
3	Biological ProductsIBA 01/2018 - 06/2010
3	LigandsIBA 01/2018 - 07/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 12/2010
2	Sunitinib (Sutent)FDA Link 10/2019 - 01/2014
2	src-Family KinasesIBA 10/2019 - 08/2019
2	Oncogene Proteins (Oncogene Protein)IBA 12/2018 - 08/2010
2	Complement System Proteins (Complement)IBA 01/2018 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2018 - 06/2011
2	InterferonsIBA 12/2017 - 04/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2017 - 08/2013
2	Protein Isoforms (Isoforms)IBA 12/2010 - 06/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019
1	Plicamycin FDA Link 08/2019
1	demycarosyl-3D-digitoxosylmithramycin SKIBA 08/2019
1	saracatinibIBA 08/2019
1	DNA Ligases (Ligases, DNA)IBA 12/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2018
1	Complement C5a (Complement 5a)IBA 01/2018
1	IntegrinsIBA 01/2018
1	Histocompatibility Antigens Class IIBA 12/2017
1	Monoclonal AntibodiesIBA 04/2016
1	N-nitroso-tris-chloroethylureaIBA 04/2016
1	Thyroid Nuclear Factor 1IBA 04/2016
1	DNA (Deoxyribonucleic Acid)IBA 10/2015
1	RNA (Ribonucleic Acid)IBA 10/2015
1	SirtuinsIBA 01/2015
1	NAD (NADH)IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	tenovin-1IBA 01/2015
1	Sirtuin 1IBA 01/2015
1	Sirtuin 2IBA 01/2015
1	TNF Receptor-Associated Factor 1IBA 05/2014
1	Monomeric GTP-Binding ProteinsIBA 03/2014
1	taxaneIBA 03/2014
1	Aldehyde DehydrogenaseIBA 01/2014
1	SmokeIBA 08/2013
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 08/2013
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2013
1	CarcinogensIBA 08/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 08/2013
1	Blocking AntibodiesIBA 07/2012
1	Endothelial Protein C ReceptorIBA 07/2012
1	Protein CIBA 07/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2012
1	Collagen ReceptorsIBA 02/2012
1	CollagenIBA 02/2012
1	Discoidin Domain ReceptorsIBA 02/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2010
1	SurvivinIBA 08/2010
1	MicroRNAs (MicroRNA)IBA 04/2009
1	Macrophage Migration-Inhibitory FactorsIBA 04/2009
1	ParaffinIBA 04/2009
1	AdrenomedullinIBA 03/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2003
1	LipopolysaccharidesIBA 08/2003

Therapy/Procedure

9	Therapeutics 10/2019 - 04/2009
2	Immunotherapy 01/2022 - 04/2016
2	Drug Therapy (Chemotherapy) 10/2015 - 06/2011
2	Radiotherapy 06/2011 - 04/2009
1	Ligation 01/2018
1	Adjuvant Chemotherapy 10/2015